Li‐Xi Liao
- Molecular Biology
- Pharmacology top 10%
- Neurology top 10%
- Cancer Research
- Immunology
- Topics
- Mitochondrial Function and Pathology (5 papers)Natural product bioactivities and synthesis (5 papers)Signaling Pathways in Disease (5 papers)
In The Last Decade
Li‐Xi Liao
27 papers receiving 668 citations
Peers
Comparison fields: 5 of 85
- Molecular Biology 359
- Pharmacology 110
- Neurology 101
- Cancer Research 89
- Immunology 82
Countries citing papers authored by Li‐Xi Liao
This map shows the geographic impact of Li‐Xi Liao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li‐Xi Liao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li‐Xi Liao more than expected).
Fields of papers citing papers by Li‐Xi Liao
This network shows the impact of papers produced by Li‐Xi Liao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li‐Xi Liao. The network helps show where Li‐Xi Liao may publish in the future.
Co-authorship network of co-authors of Li‐Xi Liao
This figure shows the co-authorship network connecting the top 25 collaborators of Li‐Xi Liao. A scholar is included among the top collaborators of Li‐Xi Liao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Li‐Xi Liao. Li‐Xi Liao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 10 | |
| 3 | 3 | |
| 4 | 2 | |
| 5 | 21 | |
| 6 | 82 | |
| 7 | 2 | |
| 8 | 12 | |
| 9 | 7 | |
| 10 | 16 | |
| 11 | 25 | |
| 12 | 46 | |
| 13 | 84 | |
| 14 | 2 | |
| 15 | 28 | |
| 16 | 17 | |
| 17 | 34 | |
| 18 | 19 | |
| 19 | 22 | |
| 20 | 33 |
About Li‐Xi Liao
Li‐Xi Liao is a scholar working on Cancer Research, Complementary and alternative medicine and Neurology, having authored 27 papers that have together received 673 indexed citations. Recurring topics across this work include Mitochondrial Function and Pathology (5 papers), Natural product bioactivities and synthesis (5 papers) and Signaling Pathways in Disease (5 papers). The work is most often cited by research in Neurology (101 citations), Biological Psychiatry (20 citations) and Pharmacology (61 citations). Li‐Xi Liao has collaborated with scholars based in China, Macao and Hong Kong. Frequent co-authors include Yong Jiang, Pengfei Tu, Fangjiao Song, Ke‐Wu Zeng, Mingbo Zhao, Ke‐Wu Zeng, Hai‐Ning Lv, Peng‐Fei Tu, Ke‐Wu Zeng and Xiaomin Song. Their work appears in journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.